Galectin-3, Markers of Oxidative Stress and Renal Dysfunction in Patients With Chronic Heart Failure
OBJECTIVE: to determine levels of galectin-3, markers of renal dysfunction, and plasma oxidative stress; to assess their correlation in patients with chronic heart failure (CHF) of various severity.
MATERIAL AND METHODS: We included in this study 157 CHF patients (with documented prior myocardial infarction. Patients were divided into 3 groups according to their NYHA functional class (group 1 - class II n=60, group 2 - class III n=52, group 3 - class IV n=45). All patients underwent clinical examination, echocardiography. Laboratory parameters included measurement of plasma levels of galectin-3, NT-proBNP, as well as markers of oxidative stress (oxidized low density lipoprotein cholesterol [oxLDLC], SH-groups) and renal dysfunction (creatinine, uric acid, cystatin-C).
RESULTS: The level of galectin-3 (median) in groups 1, 2, and 3 was 10, 19 and 38 ng/ml respectively. There were significant differences between groups (p<0,001). In all groups levels of galectin-3 significantly (p<0.01) correlated with those of oxLDL (positively) and SH-groups (negatively): r1=0.52, r2=0.59, r3=0.63, p<0.01, and r1=-0.58, r2=-0.65, r3=-0.71, respectively. Correlation analysis also revealed close and moderate correlations between galectin-3 and cystatin-C, glomerular filtration rate, and uric acid.
CONCLUSIONS: In patients with CHF and prior myocardial infarction plasma concentration of galectin-3 was associated with severity of CHF and significantly correlated with markers of renal dysfunction and plasma oxidative stress.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:57 |
---|---|
Enthalten in: |
Kardiologiia - 57(2017), 3 vom: 01. März, Seite 46-50 |
Sprache: |
Russisch |
---|
Beteiligte Personen: |
Medvedeva, E A [VerfasserIn] |
---|
Anmerkungen: |
Date Completed 30.04.2018 Date Revised 04.12.2021 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM274372207 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM274372207 | ||
003 | DE-627 | ||
005 | 20231225003336.0 | ||
007 | tu | ||
008 | 231225s2017 xx ||||| 00| ||rus c | ||
028 | 5 | 2 | |a pubmed24n0914.xml |
035 | |a (DE-627)NLM274372207 | ||
035 | |a (NLM)28762935 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a rus | ||
100 | 1 | |a Medvedeva, E A |e verfasserin |4 aut | |
245 | 1 | 0 | |a Galectin-3, Markers of Oxidative Stress and Renal Dysfunction in Patients With Chronic Heart Failure |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 30.04.2018 | ||
500 | |a Date Revised 04.12.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVE: to determine levels of galectin-3, markers of renal dysfunction, and plasma oxidative stress; to assess their correlation in patients with chronic heart failure (CHF) of various severity | ||
520 | |a MATERIAL AND METHODS: We included in this study 157 CHF patients (with documented prior myocardial infarction. Patients were divided into 3 groups according to their NYHA functional class (group 1 - class II n=60, group 2 - class III n=52, group 3 - class IV n=45). All patients underwent clinical examination, echocardiography. Laboratory parameters included measurement of plasma levels of galectin-3, NT-proBNP, as well as markers of oxidative stress (oxidized low density lipoprotein cholesterol [oxLDLC], SH-groups) and renal dysfunction (creatinine, uric acid, cystatin-C) | ||
520 | |a RESULTS: The level of galectin-3 (median) in groups 1, 2, and 3 was 10, 19 and 38 ng/ml respectively. There were significant differences between groups (p<0,001). In all groups levels of galectin-3 significantly (p<0.01) correlated with those of oxLDL (positively) and SH-groups (negatively): r1=0.52, r2=0.59, r3=0.63, p<0.01, and r1=-0.58, r2=-0.65, r3=-0.71, respectively. Correlation analysis also revealed close and moderate correlations between galectin-3 and cystatin-C, glomerular filtration rate, and uric acid | ||
520 | |a CONCLUSIONS: In patients with CHF and prior myocardial infarction plasma concentration of galectin-3 was associated with severity of CHF and significantly correlated with markers of renal dysfunction and plasma oxidative stress | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a cystatin-C | |
650 | 4 | |a galectin-3 | |
650 | 4 | |a heart failure | |
650 | 4 | |a oxidative stress | |
650 | 7 | |a Biomarkers |2 NLM | |
650 | 7 | |a Blood Proteins |2 NLM | |
650 | 7 | |a Galectin 3 |2 NLM | |
650 | 7 | |a Galectins |2 NLM | |
650 | 7 | |a LGALS3 protein, human |2 NLM | |
650 | 7 | |a Lipoproteins, LDL |2 NLM | |
650 | 7 | |a Peptide Fragments |2 NLM | |
650 | 7 | |a oxidized low density lipoprotein |2 NLM | |
650 | 7 | |a pro-brain natriuretic peptide (1-76) |2 NLM | |
650 | 7 | |a Natriuretic Peptide, Brain |2 NLM | |
650 | 7 | |a 114471-18-0 |2 NLM | |
700 | 1 | |a Berezin, I I |e verfasserin |4 aut | |
700 | 1 | |a Shchukin, Y V |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Kardiologiia |d 1961 |g 57(2017), 3 vom: 01. März, Seite 46-50 |w (DE-627)NLM000007153 |x 0022-9040 |7 nnns |
773 | 1 | 8 | |g volume:57 |g year:2017 |g number:3 |g day:01 |g month:03 |g pages:46-50 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 57 |j 2017 |e 3 |b 01 |c 03 |h 46-50 |